Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STML | AMGN | GILD | VRTX | BIIB |
| Company | Stemline Therapeutic | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 12.00 | 266.83 | 67.80 | 396.88 | 196.20 |
| High | 12.10 | 267.51 | 67.89 | 398.49 | 197.73 |
| Low | 11.82 | 263.81 | 67.19 | 392.81 | 195.06 |
| Last | 11.83 | 265.44 | 67.48 | 394.71 | 196.30 |
| Change | -0.17 | -0.07 | -0.27 | -2.65 | -0.50 |
| % Change | -1.42% | -0.03% | -0.40% | -0.67% | -0.25% |
| Volume | 17,354,300 | 1,117,100 | 2,767,682 | 339,668 | 509,696 |
| 20-Day Average Volume | 2,076,345 | 2,222,152 | 6,312,113 | 882,462 | 1,073,665 |
| Previous Close | 12.00 | 265.51 | 67.75 | 397.36 | 196.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.96 | 273.84 | 70.93 | 408.59 | 209.10 |
| 20-Day Raw Stochastic | 25.45% | 5.32% | 3.03% | 2.62% | 3.17% |
| 20-Day Relative Strength | 69.80% | 38.49% | 30.83% | 36.79% | 30.04% |
| Weighted Alpha | -54.90 | +5.64 | -23.31 | +15.65 | -36.29 |
| Today's Opinion | 56% Buy | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Previous Opinion | 72% Buy | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 16% Buy | 8% Sell | 72% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.92% since 06/02/20 | -1.89% since 04/09/24 | -3.63% since 04/09/24 | -2.70% since 04/09/24 | -5.13% since 04/09/24 |
| Low | 11.82 on 06/09/20 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 | 195.09 on 04/16/24 |
| High | 12.17 on 06/03/20 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 404.69 on 04/11/24 | 205.24 on 04/12/24 |
| 1-Month | |||||
| %Chg | -2.87% since 05/08/20 | -1.34% since 03/15/24 | -8.54% since 03/15/24 | -3.47% since 03/15/24 | -10.66% since 03/15/24 |
| Low | 11.69 on 05/27/20 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 | 195.09 on 04/16/24 |
| High | 12.25 on 05/11/20 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +134.72% since 03/09/20 | -12.59% since 01/16/24 | -21.62% since 01/16/24 | -10.04% since 01/16/24 | -20.41% since 01/16/24 |
| Low | 3.21 on 03/18/20 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 | 195.09 on 04/16/24 |
| High | 12.35 on 05/04/20 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | +19.37% since 12/09/19 | -7.54% since 10/16/23 | -14.90% since 10/16/23 | +5.23% since 10/16/23 | -26.87% since 10/16/23 |
| Low | 3.21 on 03/18/20 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 341.90 on 11/16/23 | 195.09 on 04/16/24 |
| High | 12.35 on 05/04/20 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 269.43 on 10/17/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 621,205 | 142,291,856 | 84,353,968 | 102,701,272 | 28,607,044 |
| Shares Outstanding, K | 52,511 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 43,220,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -76,820,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 8,870,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -21,290,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.78 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 06/05/20 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.13 | 29.51 | 13.45 |